ALPS Industry Partners
We are proud to present our industry partners
Advanced Oxygen Therapy Inc. (AOTI) provides a unique cyclical-pressurized Topical Wound Oxygen (TWO2) therapy that’s RCT & RWE proven to heal chronic wounds more durably, resulting in significant reductions in hospitalizations and amputations. TWO2 is a multi-modality homecare approach that combines higher pressure oxygen delivery, with cyclical non-contact compression and humidification. TWO2, Proven to Deliver Sustained Wound Healing and Preventing Amputations, So Life Can Get Back to Normal…
Visit AOTI at https://aotinc.net/ and learn more
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
As a leader in nutrition science, research and development, Abbott’s goal is to deliver nutrition products and education that meet the changing needs of families across the world. We make products to help babies and children grow, that work to keep bodies strong, and that support the unique nutritional and therapeutic needs of adults. This includes Juven, a nutritional drink mix to help support wound healing in various wound types including diabetic foot ulcers, vascular ulcers, pressure injuries and surgical wounds.
Nutrition is the foundation to healthy living and here at Abbott Nutrition, we provide resources to help people live their best life. Learn more at www.abbottnutrition.com. Learn more about Juven for wound healing at www.Juven.com.
Nevro is a medical device company based in Redwood City, CA that has the simple goal of helping more patients suffering from chronic pain achieve lasting relief. On 7/16/21, Nevro became the only spinal cord stimulation (SCS) company to receive FDA approval for an expanded indication for its Senza SCS System to treat patients with pain of the lower limbs associated with diabetic neuropathy. Nevro conducted the largest RCT to date, studying SCS in patients with diabetic neuropathy.